Skip to content

Clinical trials

Completed Phase 3 Liver Cirrhosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 3 Status: Completed Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20032
20064
20071
20081
20105
20112
20121
20132
20161
20181
20191
20201
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Aga Khan University1
Bambino Gesù Hospital and Research Institute1
Baxter Healthcare Corporation1
Beijing Continent Pharmaceutical Co, Ltd.1
Biotest Pharmaceuticals Corporation1
Cairo University1
Chugai Pharmaceutical1
Cristian Ichim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis37
Fibrosis9
Esophageal and Gastric Varices7
Hepatitis C7
Hepatitis C, Chronic7
Hypertension, Portal5
Ascites3
Liver Diseases3
Carcinoma, Hepatocellular2
Hepatic Encephalopathy2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.